SWX:ALCMedical Equipment
Alcon (SWX:ALC) After The RxSight Deal Is The Growth Story Already Priced In
Alcon (SWX:ALC) is back in focus after announcing a non-exclusive collaboration with RxSight to co-develop adjustable presbyopia-correcting intraocular lenses. These lenses can be fine tuned after cataract surgery.
See our latest analysis for Alcon.
At a share price of CHF56.94, Alcon has seen short term momentum pick up, with a 1 month share price return of 8.42% and 7 day gain of 5.37%. However, the 1 year total shareholder return is down 17.89%, pointing to ongoing investor caution even as...